[{"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-001", "question": "A 5-week-old term infant presents with extreme irritability, brisk pupillary light reflexes, and episodic generalized hypertonia with arching of the back. There is reportedly bilious vomiting after feeds and undigested formula in loose stools. Testing reveals a severe hyponatremia (115 mEq/L), hypochloremia, and hyperkalemia with severe metabolic acidosis. Ultrasound shows bladder wall thickening with bilateral hydroureteronephrosis but no posterior urethral valves. Plasma renin activity is markedly elevated, and serum cortisol is normal. Which of the following electrolyte management strategies is most specifically appropriate pending definitive diagnosis?", "options": ["Isotonic saline boluses followed by fluid restriction to prevent sodium loss", "Hypertonic saline with sodium polystyrene sulfonate and sodium bicarbonate", "Isotonic saline with fludrocortisone to promote renal sodium reabsorption", "Normal saline boluses and maintenance fluids with added sodium bicarbonate and potassium chloride", "Withhold all sodium and potassium, provide glucose-only intravenous fluids to minimize tubular electrolyte load"], "answer": "B", "answer_index": 1, "explanation": "This infant has classic pseudohypoaldosteronism type 1 (autosomal recessive multiple organ form) due to mutations in the epithelial sodium channel (ENaC) subunits. The key is severe renal salt-wasting with hyperkalemia and metabolic acidosis despite elevated aldosterone/renin. Correction requires hypertonic saline for severe hyponatremia, sodium polystyrene sulfonate for hyperkalemia, and sodium bicarbonate for acidosis. Fludrocortisone is ineffective since the defect is in the aldosterone receptor/target. Saline alone worsens potassium and acidosis; glucose-only fluids would exacerbate hyponatremia and shock.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: 5-week-old with salt-wasting, hyperkalemia, metabolic acidosis, elevated renin, normal cortisol, bladder wall thickening/hydroureteronephrosis (suggesting urinary tract involvement). The most likely diagnosis is pseudohypoaldosteronism type 1 (autosomal recessive, multi-organ form). The logical issue: The keyed answer (B) includes hypertonic saline, sodium polystyrene sulfonate, and sodium bicarbonate. However, in severe hyponatremia (115 mEq/L) with symptoms (irritability, hypertonia), hypertonic saline is indicated for rapid partial correction to prevent cerebral edema, but sodium polystyrene sulfonate is contraindicated in neonates/infants due to risk of intestinal necrosis, and its use is not 'most specifically appropriate' as a first-line pending diagnosis. Option D (normal saline boluses and maintenance with added sodium bicarbonate and potassium chloride) is incorrect because adding potassium chloride would worsen hyperkalemia. Option A (fluid restriction) may exacerbate dehydration in salt-wasting. Option C (fludrocortisone) is ineffective. Option E (glucose-only) would worsen hyponatremia. However, none of the options are fully appropriate for neonatal pseudohypoaldosteronism pending diagnosis: hypertonic saline for symptomatic hyponatremia is correct, but sodium polystyrene sulfonate is dangerous. Thus, the keyed answer is not the single best answer because it includes an unsafe component. The item is miskeyed. Medical accuracy issue: Sodium polystyrene sulfonate is contraindicated in neonates. Minimal fix: Replace option B with 'Hypertonic saline for symptomatic hyponatremia, with sodium bicarbonate for acidosis, and close monitoring of potassium (avoiding sodium polystyrene sulfonate in infants).'\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \"2\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: 5-week-old with salt-wasting, hyperkalemia, metabolic acidosis, elevated renin, normal cortisol, bladder wall thickening/hydroureteronephrosis (suggesting urinary tract involvement). The most likely diagnosis is pseudohypoaldosteronism type 1 (autosomal recessive, multi-organ form). The logical issue: The keyed answer (B) includes hypertonic saline, sodium polystyrene sulfonate, and sodium bicarbonate. However, in severe hyponatremia (115 mEq/L) with symptoms (irritability, hypertonia), hypertonic saline is indicated for rapid partial correction to prevent cerebral edema, but sodium polystyrene sulfonate is contraindicated in neonates/infants due to risk of intestinal necrosis, and its use is not 'most specifically appropriate' as a first-line pending diagnosis. Option D (normal saline boluses and maintenance with added sodium bicarbonate and potassium chloride) is incorrect because adding potassium chloride would worsen hyperkalemia. Option A (fluid restriction) may exacerbate dehydration in salt-wasting. Option C (fludrocortisone) is ineffective. Option E (glucose-only) would worsen hyponatremia. However, none of the options are fully appropriate for neonatal pseudohypoaldosteronism pending diagnosis: hypertonic saline for symptomatic hyponatremia is correct, but sodium polystyrene sulfonate is dangerous. Thus, the keyed answer is not the single best answer because it includes an unsafe component. The item is miskeyed. Medical accuracy issue: Sodium polystyrene sulfonate is contraindicated in neonates. Minimal fix: Replace option B with 'Hypertonic saline for symptomatic hyponatremia, with sodium bicarbonate for acidosis, and close monitoring of potassium (avoiding sodium polystyrene sulfonate in infants).'", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-002", "question": "A previously healthy 3-year-old boy is admitted with acute liver failure of unknown etiology. He develops progressive ascites, coagulopathy, and encephalopathy. While awaiting transplantation evaluation, he becomes increasingly tachycardic and hypotensive. Echocardiography shows a hyperdynamic left ventricle, increased cardiac output, and a dilated inferior vena cava with minimal respiratory variation. Pulmonary capillary wedge pressure is 6 mmHg, systemic vascular resistance is markedly low. Terlipressin is initiated but the child develops profound peripheral cyanosis and worsening respiratory distress. Which of the following is the most appropriate next step in management?", "options": ["Increase terlipressin dose and add IV norepinephrine", "Immediately stop terlipressin and start IV epoprostenol", "Stop terlipressin and initiate IV methylene blue bolus followed by infusion", "Perform emergent transjugular intrahepatic portosystemic shunt (TIPS)", "Add IV octreotide and midodrine while continuing terlipressin"], "answer": "C", "answer_index": 2, "explanation": "This patient has developed hepatopulmonary syndrome (HPS) with profound intrapulmonary shunting, worsened by terlipressin-induced pulmonary vasoconstriction. Methylene blue inhibits nitric oxide-mediated vasodilation, improving hypoxemia and hemodynamics in HPS. Continuing terlipressin or adding norepinephrine exacerbates pulmonary hypertension and shunt. Epoprostenol worsens hypotension and shunting. TIPS is contraindicated in acute liver failure with encephalopathy. Octreotide/midodrine are ineffective for HPS and may worsen splanchnic ischemia.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. The keyed answer (C, methylene blue) is not the most appropriate next step for the described scenario. The stem describes a child with acute liver failure, ascites, coagulopathy, encephalopathy, and now shock with findings of a hyperdynamic state, low SVR, and low PCWP—classic for hepatorenal syndrome type 1 (HRS-AKI) or distributive shock from systemic vasodilation, not hepatopulmonary syndrome (HPS). HPS presents with hypoxemia and intrapulmonary shunting, but the stem emphasizes hypotension and shock, not hypoxemia (cyanosis appears only after terlipressin, likely due to peripheral vasoconstriction, not HPS). Terlipressin is first-line for HRS; if ineffective or causing ischemia, stopping it and using norepinephrine is guideline-supported. Methylene blue is not standard for HPS in acute liver failure with shock. The most appropriate next step is to stop terlipressin due to adverse effects (cyanosis, respiratory distress) and start a vasopressor like norepinephrine (option A), not methylene blue. The key misidentifies the syndrome. Main logical issue: Miskeyed. Main medical accuracy issue: Incorrectly frames the problem as HPS and recommends a non-standard therapy. Minimal fix: Change the key to A and adjust the rationale to reflect terlipressin failure/adverse effects in HRS/shock management.\", \"logical_false_reason\": \"K\", \"logical_validity\": false, \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 1 column 1464 (char 1463)"}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-003", "question": "A 34-year-old woman presents to the ED 48 hours after a mountain climbing expedition above 18,000 feet. She reports severe headache, ataxia, and intermittent confusion. She was placed on high-flow oxygen, given dexamethasone 10 mg IV, and planned for descent. While awaiting helicopter transport, she develops sudden-onset facial droop, right hemiparesis, and global aphasia. Vital signs: BP 158/92, HR 110, SpO2 92% on 15L non-rebreather (previously 82%). Non-contrast head CT is normal. Which of the following is the most appropriate immediate therapeutic intervention?", "options": ["Administer IV tissue plasminogen activator (tPA) per stroke protocol", "Hyperbaric oxygen therapy in a portable chamber at the current altitude", "Immediate rapid descent to below 8,000 feet while maintaining oxygen", "Initiate IV heparin for presumed cerebral venous sinus thrombosis", "Increase dexamethasone to 20 mg IV and add acetazolamide 500 mg IV"], "answer": "B", "answer_index": 1, "explanation": "This patient has high-altitude cerebral edema (HACE) with focal neurological deficits mimicking stroke, likely from venous infarction or hemorrhage. At this extreme altitude, hyperbaric oxygen immediately reduces intracranial pressure while awaiting evacuation. tPA is contraindicated due to potential hemorrhagic component and unclear time of symptom onset. Descent is critical but will take time; in-transport hyperbaric therapy provides immediate benefit. Heparin risks hemorrhage in HACE. Increased steroids and acetazolamide are inadequate for acute deterioration with focal deficits.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: acute focal deficits (facial droop, hemiparesis, aphasia) in a patient with HACE symptoms, normal head CT, at altitude. The vignette describes a sudden focal neurological deficit meeting criteria for an acute ischemic stroke, with a normal CT ruling out hemorrhage. The most appropriate immediate intervention, per standard stroke guidelines, is IV tPA if within the time window and no contraindications—the vignette does not state contraindications. Hyperbaric oxygen (keyed answer) is not the standard immediate therapy for acute focal stroke; it is a temporizing measure for HACE but not the priority for new focal deficits. The item's logic incorrectly prioritizes altitude physiology over acute stroke management. Minimal fix: Change key to A (IV tPA) and adjust rationale to address altitude context, or add a contraindication to tPA (e.g., time >4.5 hours) to justify B.\",\n    \"medical_accuracy_score\":  \"2\",\n    \"logical_validity\": false,\n    \"logical_false_reason\": \"K\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: acute focal deficits (facial droop, hemiparesis, aphasia) in a patient with HACE symptoms, normal head CT, at altitude. The vignette describes a sudden focal neurological deficit meeting criteria for an acute ischemic stroke, with a normal CT ruling out hemorrhage. The most appropriate immediate intervention, per standard stroke guidelines, is IV tPA if within the time window and no contraindications—the vignette does not state contraindications. Hyperbaric oxygen (keyed answer) is not the standard immediate therapy for acute focal stroke; it is a temporizing measure for HACE but not the priority for new focal deficits. The item's logic incorrectly prioritizes altitude physiology over acute stroke management. Minimal fix: Change key to A (IV tPA) and adjust rationale to address altitude context, or add a contraindication to tPA (e.g., time >4.5 hours) to justify B.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-004", "question": "A 32-year-old G2P1001 at 31 weeks gestation presents with acute-onset severe abdominal pain and hypotension. Ultrasound shows a normal intrauterine pregnancy with fetal heart rate 140 bpm, but a large right adnexal complex mass with free fluid. She is taken emergently to OR for suspected ovarian torsion. Intraoperatively, the right ovary is necrotic and detorted but appears hemorrhagic with surface excrescences. Frozen section returns 'atypical cells, cannot rule out malignancy.' Which of the following is the most appropriate surgical management?", "options": ["Right oophorectomy only, preserve uterus and left adnexa", "Right oophorectomy with right pelvic lymph node sampling", "Right oophorectomy with infracolic omentectomy and pelvic washings", "Right salpingo-oophorectomy with left ovarian biopsy and appendectomy", "Proceed with total abdominal hysterectomy with bilateral salpingo-oophorectomy"], "answer": "C", "answer_index": 2, "explanation": "In pregnancy with suspected ovarian cancer, staging should be as complete as possible while preserving the pregnancy. Omentectomy and washings provide critical staging information without compromising uterine blood supply or requiring extensive dissection near the gravid uterus. Lymph node sampling is not recommended in pregnancy due to risk of hemorrhage near iliac vessels; full lymphadenectomy can wait until postpartum. Appendectomy is only indicated for mucinous tumors. Hysterectomy terminates pregnancy unnecessarily; ovarian biopsy of normal ovary is not indicated. Frozen section limitations necessitate complete staging for definitive management decisions.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: 31 weeks gestation, acute ovarian torsion with necrotic ovary, frozen section shows 'atypical cells, cannot rule out malignancy.' The question asks for most appropriate surgical management given the intraoperative findings and pregnancy. The keyed answer (C: Right oophorectomy with infracolic omentectomy and pelvic washings) is not the single best answer. For a pregnant patient with a suspicious ovarian mass where malignancy cannot be ruled out, the standard of care is to perform a unilateral oophorectomy (or salpingo-oophorectomy) to remove the mass, and defer full surgical staging (including omentectomy, lymph node sampling, and contralateral ovarian biopsy) until after delivery, unless there is obvious metastatic disease or the patient agrees to pregnancy termination. Performing an omentectomy at 31 weeks, especially an infracolic omentectomy, involves significant dissection near the gravid uterus and carries risk without clear benefit, as definitive diagnosis and full staging can be postponed. Option A (Right oophorectomy only) is the most appropriate and conservative approach to remove the concerning mass while preserving the pregnancy, with plans for definitive staging postpartum. Logical issue: The key (C) is not the best answer; the best answer is A. Medical accuracy issue: Recommending omentectomy during pregnancy for a suspicious but not confirmed malignancy is not standard; staging is typically deferred. Minimal fix: Change the key to A and adjust the rationale to reflect that staging procedures are deferred until after delivery in pregnancy unless metastatic disease is evident or patient chooses otherwise.\", \"logical_false_reason\": \"K\", \"logical_validity\": false, \"medical_accuracy_score\": \t\"3\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: 31 weeks gestation, acute ovarian torsion with necrotic ovary, frozen section shows 'atypical cells, cannot rule out malignancy.' The question asks for most appropriate surgical management given the intraoperative findings and pregnancy. The keyed answer (C: Right oophorectomy with infracolic omentectomy and pelvic washings) is not the single best answer. For a pregnant patient with a suspicious ovarian mass where malignancy cannot be ruled out, the standard of care is to perform a unilateral oophorectomy (or salpingo-oophorectomy) to remove the mass, and defer full surgical staging (including omentectomy, lymph node sampling, and contralateral ovarian biopsy) until after delivery, unless there is obvious metastatic disease or the patient agrees to pregnancy termination. Performing an omentectomy at 31 weeks, especially an infracolic omentectomy, involves significant dissection near the gravid uterus and carries risk without clear benefit, as definitive diagnosis and full staging can be postponed. Option A (Right oophorectomy only) is the most appropriate and conservative approach to remove the concerning mass while preserving the pregnancy, with plans for definitive staging postpartum. Logical issue: The key (C) is not the best answer; the best answer is A. Medical accuracy issue: Recommending omentectomy during pregnancy for a suspicious but not confirmed malignancy is not standard; staging is typically deferred. Minimal fix: Change the key to A and adjust the rationale to reflect that staging procedures are deferred until after delivery in pregnancy unless metastatic disease is evident or patient chooses otherwise.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-005", "question": "A 42-year-old man with treatment-resistant schizophrenia on clozapine 450 mg daily develops acute urinary retention and obtundation. He was recently started on diphenhydramine 50 mg nightly for insomnia. In the ED, temperature is 38.9°C, HR 128, BP 168/102. He is diaphoretic, rigid, and incontinent of urine with myoclonus. Creatine kinase is 12,000 U/L, white count 18,000/mm³. After stopping all medications, which of the following is the most specific initial treatment?", "options": ["IV dantrolene 2.5 mg/kg", "IV bromocriptine 2.5 mg three times daily", "Oral cyproheptadine 12 mg loading dose", "IV physostigmine 1-2 mg", "IV lorazepam 2 mg every hour"], "answer": "D", "answer_index": 3, "explanation": "This is anticholinergic delirium with clozapine-diphenhydramine toxicity mimicking neuroleptic malignant syndrome (NMS). Physostigmine reverses central anticholinergic toxicity and helps differentiate from NMS. Dantrolene is for malignant hyperthermia, not anticholinergic crisis. Bromocriptine may worsen psychosis and is ineffective for anticholinergic toxicity. Cyproheptadine is for serotonin syndrome. Lorazepam addresses agitation but doesn't reverse anticholinergic blockade. The urinary retention, myoclonus, and recent antihistamine addition suggest anticholinergic crisis rather than pure NMS, though clozapine can cause both.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: acute urinary retention, obtundation, recent diphenhydramine, fever, tachycardia, hypertension, diaphoresis, rigidity, incontinence, myoclonus, elevated CK and WBC. The presentation strongly suggests neuroleptic malignant syndrome (NMS) given clozapine use, fever, rigidity, autonomic instability, and elevated CK. Anticholinergic toxicity typically presents with dry skin, not diaphoresis; myoclonus is more typical of serotonin syndrome. The most specific initial treatment for NMS is supportive care and stopping offending agents, with dantrolene or bromocriptine as specific therapies. IV physostigmine is not indicated for NMS and carries risk in this setting. Main logical issue: The keyed answer (D) is not the best supported by the vignette; the best answer is either A or B for NMS. Main medical accuracy issue: The rationale incorrectly frames this as anticholinergic delirium despite diaphoresis and rigidity, which are not typical. Minimal fix: Change the key to A or B, or revise the vignette to clearly indicate anticholinergic toxicity (e.g., dry skin, absent reflexes, hallucinations).\", \"logical_false_reason\": \"K\", \"logical_validity\": false, \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 1 column 1281 (char 1280)"}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-006", "question": "A 28-year-old woman with borderline personality disorder presents after ingesting 100 tablets of acetaminophen 500 mg. She presents 30 hours post-ingestion with normal vital signs and normal mental status. AST is 850 U/L, INR is 1.8, creatinine is 1.2 mg/dL. IV N-acetylcysteine (NAC) is initiated. Six hours into the infusion, she develops acute respiratory distress, wheezing, facial edema, and hypotension. After stopping NAC and administering diphenhydramine and methylprednisolone, her symptoms resolve. Her AST has risen to 2,100 U/L. Which of the following is the most appropriate next step?", "options": ["Continue NAC at a reduced rate with diphenhydramine premedication", "Switch to oral NAC 140 mg/kg followed by 70 mg/kg every 4 hours", "Begin high-flux hemodialysis to remove acetaminophen and NAC", "Administer cimetidine 300 mg IV every 6 hours as NAC alternative", "Initiate IV L-ornithine L-aspartate and silibinin as hepatoprotective agents"], "answer": "B", "answer_index": 1, "explanation": "Oral NAC is equally effective as IV for acetaminophen toxicity and should be used when IV causes anaphylactoid reactions. Continuing IV NAC with premedication risks recurrent reaction and hypotension. Hemodialysis does not effectively remove acetaminophen or NAC metabolites. Cimetidine has limited evidence and insufficient hepatoprotection. L-ornithine and silibinin are unproven in acute overdose. Since the patient presented late with established hepatotoxicity, completion of NAC via oral route is critical for glutathione repletion despite initial reaction to IV formulation.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: Late-presenting acetaminophen overdose with established hepatotoxicity (AST 2100) and anaphylactoid reaction to IV NAC. The most appropriate next step after a severe anaphylactoid reaction to IV NAC is to continue NAC via the oral route, which is standard of care. However, option B states 'Switch to oral NAC 140 mg/kg followed by 70 mg/kg every 4 hours.' This is the standard oral regimen, but the patient is already 30 hours post-ingestion and 6 hours into IV NAC. The standard 21-hour IV protocol or 72-hour oral protocol timing is disrupted. The keyed answer is medically correct in principle, but the specific dosing in option B is for the initial loading dose and maintenance doses of the oral protocol, which may not align with the interrupted IV infusion. More critically, option A ('Continue NAC at a reduced rate with diphenhydramine premedication') is also defensible per some guidelines for mild reactions, but given the severity (hypotension, respiratory distress), switching to oral is preferred. However, the item is slightly underspecified regarding the exact timing of the oral regimen relative to the interrupted IV, but the keyed answer is broadly correct. The main logical issue is miskeying because option A could be considered by some, but guidelines strongly favor oral route after severe reaction. Medical accuracy: The rationale correctly states oral NAC is effective, but the dosing in option B might be misinterpreted as the full oral protocol initiation, which is appropriate. No major inaccuracies. Minimal fix: Clarify in stem that the patient has received only 6 hours of IV NAC and specify the need to complete a full NAC course, making B unequivocally best.\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\": \n  \"4\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: Late-presenting acetaminophen overdose with established hepatotoxicity (AST 2100) and anaphylactoid reaction to IV NAC. The most appropriate next step after a severe anaphylactoid reaction to IV NAC is to continue NAC via the oral route, which is standard of care. However, option B states 'Switch to oral NAC 140 mg/kg followed by 70 mg/kg every 4 hours.' This is the standard oral regimen, but the patient is already 30 hours post-ingestion and 6 hours into IV NAC. The standard 21-hour IV protocol or 72-hour oral protocol timing is disrupted. The keyed answer is medically correct in principle, but the specific dosing in option B is for the initial loading dose and maintenance doses of the oral protocol, which may not align with the interrupted IV infusion. More critically, option A ('Continue NAC at a reduced rate with diphenhydramine premedication') is also defensible per some guidelines for mild reactions, but given the severity (hypotension, respiratory distress), switching to oral is preferred. However, the item is slightly underspecified regarding the exact timing of the oral regimen relative to the interrupted IV, but the keyed answer is broadly correct. The main logical issue is miskeying because option A could be considered by some, but guidelines strongly favor oral route after severe reaction. Medical accuracy: The rationale correctly states oral NAC is effective, but the dosing in option B might be misinterpreted as the full oral protocol initiation, which is appropriate. No major inaccuracies. Minimal fix: Clarify in stem that the patient has received only 6 hours of IV NAC and specify the need to complete a full NAC course, making B unequivocally best.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-007", "question": "A 65-year-old man with major depressive disorder and chronic back pain develops serotonin syndrome after starting tramadol. He is managed with discontinuation of serotonergic agents and supportive care. One week later, he develops acute severe myoclonus, rigidity, hyperthermia (40.2°C), and autonomic instability. He had been started on olanzapine 5 mg daily four days prior for agitation. Creatine kinase is 25,000 U/L. Which of the following pathophysiological mechanisms best explains this paradoxical deterioration?", "options": ["Dopamine receptor upregulation causing rebound hyperdopaminergic state", "Serotonin transporter internalization leading to synaptic serotonin accumulation", "Gamma-aminobutyric acid (GABA) depletion from prolonged muscle activity", "Malignant catatonia triggered by antipsychotic withdrawal", "N-methyl-D-aspartate (NMDA) receptor hypofunction secondary to serotonin depletion"], "answer": "E", "answer_index": 4, "explanation": "This represents the serotonin syndrome-neuroleptic malignant syndrome (NMS) overlap or 'serotonin-NMS syndrome' where serotonin depletion following serotonin syndrome predisposes to NMDA receptor hypofunction, creating vulnerability to NMS when antipsychotics are introduced. Dopamine upregulation doesn't occur this rapidly. Serotonin transporter internalization would reduce, not increase, serotonin. GABA depletion is not a recognized mechanism. Malignant catatonia typically evolves more slowly. The sequence of serotonin syndrome followed by antipsychotic exposure with severe hyperthermia and rigidity suggests NMDA hypofunction as the bridge between these syndromes.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. The stem describes a patient with recent serotonin syndrome, then olanzapine initiation, now presenting with severe hyperthermia, rigidity, autonomic instability, and markedly elevated CK. This classic presentation is neuroleptic malignant syndrome (NMS), a well-known complication of antipsychotics like olanzapine. The keyed answer (E) proposes NMDA receptor hypofunction secondary to serotonin depletion as the best pathophysiological mechanism, but this is a speculative and non-standard explanation. The most widely accepted and best-supported mechanism for NMS is central D2 receptor blockade (a dopaminergic mechanism), which aligns with option A (dopamine receptor upregulation causing rebound hyperdopaminergic state) though 'upregulation' may not be precise. Option A is closer to mainstream pathophysiology than E. The item is medically inaccurate in promoting a fringe theory as the 'best' explanation. Main logical issue: key mismatch. Main medical issue: the keyed answer is not the most defensible based on standard knowledge. Minimal fix: Change key to A and revise rationale to focus on dopamine receptor blockade, or reword option A to 'Dopamine receptor blockade leading to hypodopaminergic state' and keep as key.\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\": \n  \"2\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. The stem describes a patient with recent serotonin syndrome, then olanzapine initiation, now presenting with severe hyperthermia, rigidity, autonomic instability, and markedly elevated CK. This classic presentation is neuroleptic malignant syndrome (NMS), a well-known complication of antipsychotics like olanzapine. The keyed answer (E) proposes NMDA receptor hypofunction secondary to serotonin depletion as the best pathophysiological mechanism, but this is a speculative and non-standard explanation. The most widely accepted and best-supported mechanism for NMS is central D2 receptor blockade (a dopaminergic mechanism), which aligns with option A (dopamine receptor upregulation causing rebound hyperdopaminergic state) though 'upregulation' may not be precise. Option A is closer to mainstream pathophysiology than E. The item is medically inaccurate in promoting a fringe theory as the 'best' explanation. Main logical issue: key mismatch. Main medical issue: the keyed answer is not the most defensible based on standard knowledge. Minimal fix: Change key to A and revise rationale to focus on dopamine receptor blockade, or reword option A to 'Dopamine receptor blockade leading to hypodopaminergic state' and keep as key.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-008", "question": "A 58-year-old man undergoes robotic-assisted laparoscopic prostatectomy for Gleason 4+3=7 adenocarcinoma. On postoperative day 2, he develops abdominal distension and ileus. CT scan demonstrates a 3 cm retroperitoneal urinoma at the vesicourethral anastomosis. A percutaneous drain is placed, output is 200 mL/day of urine. After two weeks, drain output remains 150 mL/day despite Foley catheter drainage. Retrograde cystogram shows no leak. Which of the following is the most appropriate intervention to achieve closure?", "options": ["Prolonged Foley catheter drainage for 4-6 weeks", "Endoscopic placement of double-J ureteral stent", "Percutaneous nephrostomy tube placement", "Endoscopic injection of fibrin glue at anastomotic site", "Surgical revision of vesicourethral anastomosis"], "answer": "A", "answer_index": 0, "explanation": "For persistent urinoma after prostatectomy with no evidence of active leak on cystogram, the urinoma represents a 'urinoma cavity' that must collapse and seal. Prolonged Foley drainage (4-6 weeks) allows gradual collapse and healing. Ureteral stent or nephrostomy diverts urine but doesn't address the dead space. Fibrin glue injection risks infection and rarely works for established cavities. Surgical revision carries high morbidity and is rarely needed for small persistent drainage. The key is recognizing that low-output drainage from a drain may represent residual cavity fluid rather than active leak, requiring time rather than invasive intervention.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: Persistent low-output (150 mL/day) drain output after two weeks of percutaneous drainage and Foley catheter, retrograde cystogram shows no leak. This indicates no active extravasation, but a persistent urinoma cavity. The most appropriate intervention to achieve closure is to ensure complete urinary diversion to allow the cavity to collapse and heal. Prolonged Foley drainage alone (option A) may be insufficient because the drain output suggests ongoing collection; definitive management typically involves maximizing urinary diversion, often with percutaneous nephrostomy (option C) to divert urine completely and allow the cavity to seal. Option A is not the best because low-output drainage despite Foley suggests the need for more effective diversion. Option C is superior as it diverts urine proximally, reducing pressure and flow to the anastomosis, promoting healing. Main logical issue: Keyed answer A is not the single best answer; option C is more appropriate based on standard urologic management of persistent urinoma after cystogram shows no leak. Main medical accuracy issue: While prolonged Foley drainage is sometimes used, for persistent drainage after two weeks with a drain still in place, percutaneous nephrostomy is often indicated to achieve closure. Minimal fix: Change key to C, or adjust stem to specify that drain output has ceased, making prolonged Foley drainage appropriate.\", \"logical_false_reason\": \"K\", \"logical_validity\": false, \"medical_accuracy_score\":  \"3\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: Persistent low-output (150 mL/day) drain output after two weeks of percutaneous drainage and Foley catheter, retrograde cystogram shows no leak. This indicates no active extravasation, but a persistent urinoma cavity. The most appropriate intervention to achieve closure is to ensure complete urinary diversion to allow the cavity to collapse and heal. Prolonged Foley drainage alone (option A) may be insufficient because the drain output suggests ongoing collection; definitive management typically involves maximizing urinary diversion, often with percutaneous nephrostomy (option C) to divert urine completely and allow the cavity to seal. Option A is not the best because low-output drainage despite Foley suggests the need for more effective diversion. Option C is superior as it diverts urine proximally, reducing pressure and flow to the anastomosis, promoting healing. Main logical issue: Keyed answer A is not the single best answer; option C is more appropriate based on standard urologic management of persistent urinoma after cystogram shows no leak. Main medical accuracy issue: While prolonged Foley drainage is sometimes used, for persistent drainage after two weeks with a drain still in place, percutaneous nephrostomy is often indicated to achieve closure. Minimal fix: Change key to C, or adjust stem to specify that drain output has ceased, making prolonged Foley drainage appropriate.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-009", "question": "A 45-year-old woman with neurofibromatosis type 1 presents with progressive paraparesis over 3 months. MRI shows a large enhancing intradural extramedullary mass at T4-T7 displacing the spinal cord, with multiple neuroforaminal extensions. During resection, the tumor is found to be highly vascular and adherent to multiple nerve roots. Intraoperative monitoring shows loss of motor evoked potentials (MEPs) in the lower extremities after partial debulking. Which of the following is the most appropriate intraoperative response?", "options": ["Abort surgery and close; plan for postoperative stereotactic radiosurgery", "Continue resection; MEP loss may be temporary with tumor manipulation", "Administer high-dose methylprednisolone and continue with subtotal resection", "Obtain immediate intraoperative frozen section to rule out malignant transformation", "Switch to intracapsular ultrasonic aspiration to minimize nerve root traction"], "answer": "A", "answer_index": 0, "explanation": "In spinal schwannomas (common in NF1), persistent loss of MEPs during resection indicates significant spinal cord ischemia or injury, likely from vascular compromise of the anterior spinal artery via tumor feeders. Continuing risks permanent paraplegia. Temporary MEP changes typically recover within minutes; persistent loss mandates stopping. Steroids are inadequate for vascular injury. Frozen section doesn't change acute management. Ultrasonic aspiration still risks vascular injury. The appropriate approach is to stop, preserve neurological function, and use stereotactic radiosurgery for residual tumor, which is effective for schwannomas and avoids surgical morbidity.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: NF1 patient, enhancing intradural extramedullary mass with foraminal extensions (classic for spinal schwannoma), persistent MEP loss after partial debulking indicating spinal cord ischemia/injury. The item logically leads to stopping surgery to prevent permanent deficit, as continuing risks paraplegia. Alternatives are inferior: B ignores persistent loss; C is ineffective for vascular injury; D does not change acute management; E still risks vascular compromise. Medical accuracy is sound: persistent MEP loss is a standard indication to abort, and radiosurgery is accepted for residual benign nerve sheath tumors. Minimal fix: none needed; item is clear and accurate.\",\n  \"medical_accuracy_score\":  \"5\",\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. Key stem clues: NF1 patient, enhancing intradural extramedullary mass with foraminal extensions (classic for spinal schwannoma), persistent MEP loss after partial debulking indicating spinal cord ischemia/injury. The item logically leads to stopping surgery to prevent permanent deficit, as continuing risks paraplegia. Alternatives are inferior: B ignores persistent loss; C is ineffective for vascular injury; D does not change acute management; E still risks vascular compromise. Medical accuracy is sound: persistent MEP loss is a standard indication to abort, and radiosurgery is accepted for residual benign nerve sheath tumors. Minimal fix: none needed; item is clear and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-010", "question": "A 72-year-old man with Gleason 4+5=9 adenocarcinoma of the prostate, cT3bN1M0, completes definitive intensity-modulated radiation therapy (IMRT) to prostate and pelvis to 79.2 Gy with 2 years of androgen deprivation therapy (ADT). Six months after completing ADT, PSA rises to 5.2 ng/mL. Ga-68 PSMA PET/CT shows isolated PSMA-avid retroperitoneal lymph node measuring 1.8 cm at the aortocaval confluence, SUVmax 12.5. Which of the following represents the most appropriate definitive management?", "options": ["Salvage extended field radiotherapy to include the retroperitoneum", "Systemic therapy with enzalutamide or abiraterone", "Metastasis-directed stereotactic body radiotherapy (SBRT) to the involved node", "Retroperitoneal lymph node dissection", "Re-initiation of ADT with docetaxel chemotherapy"], "answer": "C", "answer_index": 2, "explanation": "For oligorecurrent prostate cancer with a single PSMA-avid node, metastasis-directed therapy with SBRT offers durable control with minimal toxicity compared to systemic therapy or extended field RT. The STOMP and ORIOLE trials support this approach. Extended field radiotherapy to abdomen would have significant bowel toxicity. Systemic therapy is premature for solitary metastasis. Retroperitoneal lymph node dissection carries morbidity and may not be curative. Re-initiating ADT with chemotherapy is overtreatment for oligometastatic disease. SBRT provides local control while delaying systemic therapy and its side effects.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: Gleason 9, cT3bN1M0, prior definitive IMRT + 2 years ADT, PSA rise to 5.2 ng/mL after ADT completion, Ga-68 PSMA PET/CT shows isolated PSMA-avid retroperitoneal node (1.8 cm, SUVmax 12.5). The scenario describes oligorecurrent prostate cancer (single metastasis) after prior aggressive local therapy. Main logical issue: None; the stem provides sufficient detail to support metastasis-directed therapy (SBRT) as the most appropriate definitive management per current guidelines and trials (e.g., STOMP, ORIOLE). Main medical accuracy issue: None; the keyed answer aligns with standard of care for oligometastatic prostate cancer. Minimal fix: None required; the item is clear and accurate. However, to further emphasize the 'definitive management' intent, one could specify 'with curative intent' in the stem.\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\": \n  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: Gleason 9, cT3bN1M0, prior definitive IMRT + 2 years ADT, PSA rise to 5.2 ng/mL after ADT completion, Ga-68 PSMA PET/CT shows isolated PSMA-avid retroperitoneal node (1.8 cm, SUVmax 12.5). The scenario describes oligorecurrent prostate cancer (single metastasis) after prior aggressive local therapy. Main logical issue: None; the stem provides sufficient detail to support metastasis-directed therapy (SBRT) as the most appropriate definitive management per current guidelines and trials (e.g., STOMP, ORIOLE). Main medical accuracy issue: None; the keyed answer aligns with standard of care for oligometastatic prostate cancer. Minimal fix: None required; the item is clear and accurate. However, to further emphasize the 'definitive management' intent, one could specify 'with curative intent' in the stem.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-011", "question": "A 9-month-old exclusively breastfed infant presents with severe metabolic acidosis (pH 7.18), lactic acidosis, hyperammonemia (250 μmol/L), and hypoglycemia. Urine organic acids show elevated 3-hydroxyisovalerylcarnitine, 3-methylglutaconate, and 3-hydroxy-3-methylglutarate. Plasma acylcarnitine profile reveals elevated C5-OH. The infant develops acute neurological deterioration with abnormal eye movements. Which of the following is the most urgent specific intervention?", "options": ["IV carnitine 100 mg/kg", "IV riboflavin 100 mg", "IV biotin 10 mg", "Oral glycine 250 mg/kg", "IV sodium benzoate 250 mg/kg"], "answer": "C", "answer_index": 2, "explanation": "The biochemical profile indicates multiple carboxylase deficiency (biotinidase or holocarboxylase synthetase deficiency). Biotin is the cofactor for all four carboxylases, and high-dose IV biotin can rapidly reverse the metabolic crisis. Carnitine may help with secondary deficiency but doesn't address the primary defect. Riboflavin is for multiple acyl-CoA dehydrogenase deficiency (glutaric aciduria type II). Glycine is for isovaleric acidemia. Sodium benzoate is for hyperammonemia but does not correct carboxylase deficiency. The neurological symptoms may include seizures and coma requiring emergent biotin administration before confirmatory enzyme testing.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: exclusively breastfed infant, severe metabolic acidosis with lactic acidosis, hyperammonemia, hypoglycemia, urine organic acids showing elevated 3-hydroxyisovalerylcarnitine, 3-methylglutaconate, and 3-hydroxy-3-methylglutarate, plasma acylcarnitine with elevated C5-OH, acute neurological deterioration. This pattern is classic for multiple carboxylase deficiency (biotinidase or holocarboxylase synthetase deficiency). The most urgent specific intervention is high-dose IV biotin to provide the missing cofactor. The keyed answer (C) is correct. Alternatives: carnitine (A) is supportive but not primary; riboflavin (B) is for glutaric aciduria type II; glycine (D) is for isovaleric acidemia; sodium benzoate (E) treats hyperammonemia but doesn't correct the underlying defect. No logical contradictions; the item is well-specified and medically accurate. Minimal fix: None needed; the item is clear and defensible.\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\": \n  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. Key stem clues: exclusively breastfed infant, severe metabolic acidosis with lactic acidosis, hyperammonemia, hypoglycemia, urine organic acids showing elevated 3-hydroxyisovalerylcarnitine, 3-methylglutaconate, and 3-hydroxy-3-methylglutarate, plasma acylcarnitine with elevated C5-OH, acute neurological deterioration. This pattern is classic for multiple carboxylase deficiency (biotinidase or holocarboxylase synthetase deficiency). The most urgent specific intervention is high-dose IV biotin to provide the missing cofactor. The keyed answer (C) is correct. Alternatives: carnitine (A) is supportive but not primary; riboflavin (B) is for glutaric aciduria type II; glycine (D) is for isovaleric acidemia; sodium benzoate (E) treats hyperammonemia but doesn't correct the underlying defect. No logical contradictions; the item is well-specified and medically accurate. Minimal fix: None needed; the item is clear and defensible.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-012", "question": "A 4-year-old boy with DiGeorge syndrome (22q11.2 deletion) develops pneumonia requiring hospitalization. He has previously undergone complete repair of tetralogy of Fallot and receives supplemental calcium and vitamin D for hypoparathyroidism. During hospitalization, he develops refractory hypocalcemia (ionized calcium 0.8 mmol/L) despite IV calcium gluconate. ECG shows prolonged QTc interval. Parathyroid hormone is undetectable. Which of the following electrolyte abnormalities most likely explains the calcium refractory to therapy?", "options": ["Hypomagnesemia (0.9 mg/dL)", "Hyperphosphatemia (8.2 mg/dL)", "Metabolic alkalosis (pH 7.48)", "Hyperkalemia (6.2 mEq/L)", "Hyponatremia (125 mEq/L)"], "answer": "A", "answer_index": 0, "explanation": "In DiGeorge syndrome with hypoparathyroidism, refractory hypocalcemia is most commonly due to hypomagnesemia, as magnesium is required for PTH secretion and end-organ response. Magnesium deficiency impairs both PTH release (already absent here) and the ability of administered PTH/calcium to maintain calcium levels. Hyperphosphatemia can lower calcium but doesn't cause refractoriness to IV calcium. Alkalosis increases protein binding but not true refractoriness. Hyperkalemia and hyponatremia don't directly affect calcium responsiveness. Magnesium repletion must precede effective calcium management in this setting.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: DiGeorge syndrome with known hypoparathyroidism, refractory hypocalcemia despite IV calcium, undetectable PTH, prolonged QTc, and the question asks for the electrolyte abnormality most likely explaining refractoriness. Main logical issue: None; the stem provides sufficient detail to uniquely support hypomagnesemia as the cause of calcium refractoriness in this context. Main medical accuracy issue: None; the association between hypomagnesemia and refractory hypocalcemia in hypoparathyroidism is well-established. Minimal fix: None required; the item is clear and accurate. However, to enhance discrimination, one could explicitly state that magnesium levels were checked and found low, but the provided option value (0.9 mg/dL) already implies hypomagnesemia.\", \"logical_false_reason\": \"T\", \"logical_validity\": true, \"medical_accuracy_score\":  \"5\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: DiGeorge syndrome with known hypoparathyroidism, refractory hypocalcemia despite IV calcium, undetectable PTH, prolonged QTc, and the question asks for the electrolyte abnormality most likely explaining refractoriness. Main logical issue: None; the stem provides sufficient detail to uniquely support hypomagnesemia as the cause of calcium refractoriness in this context. Main medical accuracy issue: None; the association between hypomagnesemia and refractory hypocalcemia in hypoparathyroidism is well-established. Minimal fix: None required; the item is clear and accurate. However, to enhance discrimination, one could explicitly state that magnesium levels were checked and found low, but the provided option value (0.9 mg/dL) already implies hypomagnesemia.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-013", "question": "A 19-year-old competitive free-diver presents to the ED 60 minutes after a 45-meter dive. He developed chest pain and hemoptysis upon surfacing. He is tachycardic, hypotensive, and hypoxic. Chest CT shows bilateral ground-glass opacities and pneumomediastinum. He is intubated for worsening hypoxia. During mechanical ventilation, he develops sudden cardiovascular collapse with pulseless electrical activity. Which of the following is the most appropriate immediate intervention?", "options": ["Needle decompression of both chests", "Initiating venoarterial extracorporeal membrane oxygenation (ECMO)", "Immediate hyperbaric oxygen therapy", "Administering IV epinephrine 1 mg", "Performing pericardiocentesis"], "answer": "B", "answer_index": 1, "explanation": "This diver has arterial gas embolism (AGE) with catastrophic decompression sickness. Cardiovascular collapse in AGE represents massive air in coronary or cerebral arteries. ECMO provides immediate cardiopulmonary support while allowing time for bubble resolution and prevents further air aspiration during chest compressions. Needle decompression is for tension pneumothorax, not AGE. Hyperbaric oxygen is definitive but cannot be performed during cardiac arrest. Epinephrine may worsen air trapping through bronchodilation. Pericardiocentesis is not indicated without pericardial effusion. ECMO is increasingly used in diving-related catastrophic AGE as a bridge to hyperbaric treatment.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: 45-meter dive, immediate post-surfacing chest pain/hemoptysis, CT findings of pneumomediastinum and ground-glass opacities, and PEA arrest after intubation—collectively diagnostic of severe arterial gas embolism (AGE). The clinical scenario uniquely supports ECMO as the immediate intervention during cardiac arrest, as it provides circulatory support and facilitates bubble resolution while enabling transport to hyperbaric therapy. Needle decompression (A) is incorrect without tension pneumothorax evidence; hyperbaric oxygen (C) is definitive but not feasible during arrest; epinephrine (D) may exacerbate air trapping; pericardiocentesis (E) lacks indication. No logical contradictions or underspecification exist. Medical accuracy is sound, reflecting current resuscitation guidelines for catastrophic AGE. Minimal fix: None required; item is clear and defensible.\",\n  \"medical_accuracy_score\":  \"5\",\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: 45-meter dive, immediate post-surfacing chest pain/hemoptysis, CT findings of pneumomediastinum and ground-glass opacities, and PEA arrest after intubation—collectively diagnostic of severe arterial gas embolism (AGE). The clinical scenario uniquely supports ECMO as the immediate intervention during cardiac arrest, as it provides circulatory support and facilitates bubble resolution while enabling transport to hyperbaric therapy. Needle decompression (A) is incorrect without tension pneumothorax evidence; hyperbaric oxygen (C) is definitive but not feasible during arrest; epinephrine (D) may exacerbate air trapping; pericardiocentesis (E) lacks indication. No logical contradictions or underspecification exist. Medical accuracy is sound, reflecting current resuscitation guidelines for catastrophic AGE. Minimal fix: None required; item is clear and defensible.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-014", "question": "A 28-year-old G2P0010 at 7 weeks gestation presents with vaginal bleeding and lower abdominal pain. Quantitative β-hCG is 850 mIU/mL. Transvaginal ultrasound shows no intrauterine gestational sac, normal bilateral ovaries, and minimal free fluid in the cul-de-sac. Two days later, repeat β-hCG is 1,100 mIU/mL. Diagnostic laparoscopy reveals a 1 cm blue-bulge on the left fallopian tube consistent with ectopic pregnancy. Which of the following is the most appropriate management?", "options": ["Systemic methotrexate (MTX) 50 mg/m²", "Salpingostomy with preservation of the fallopian tube", "Segmental resection of the affected tubal portion", "Salpingectomy", "Expectant management with weekly β-hCG monitoring"], "answer": "D", "answer_index": 3, "explanation": "For ectopic pregnancy with β-hCG <2000 and small size, MTX is usually first-line. However, this patient has already undergone diagnostic laparoscopy, making surgical management more appropriate than switching to medical therapy. Given she is G2P0 with no living children, preservation might be considered, but studies show similar future fertility with salpingectomy versus salpingostomy, and salpingectomy eliminates risk of persistent ectopic tissue. Segmental resection is for isthmic ectopics when anastomosis is planned. Expectant management is inappropriate with visualized ectopic. Salpingostomy carries 5-20% risk of persistent trophoblast requiring additional treatment. Salpingectomy provides definitive treatment during the established surgical encounter.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: ectopic pregnancy visualized at laparoscopy, β-hCG <2000 mIU/mL, small size (1 cm), hemodynamically stable (implied by elective laparoscopy). Main logical issue: The keyed answer (D, salpingectomy) is not the single best answer; option A (methotrexate) is equally defensible per standard guidelines for a small, low-β-hCG ectopic in a stable patient, even after diagnostic laparoscopy, as medical management remains a valid first-line option. The stem lacks critical details (e.g., patient's desire for future fertility, surgeon's assessment of tube viability, or explicit contraindication to methotrexate) to uniquely favor surgery over medicine. Main medical accuracy issue: The rationale overstates the inappropriateness of methotrexate post-laparoscopy; guidelines support either medical or surgical management in this scenario. Minimal fix: Add to the stem: 'The patient expresses a strong desire to preserve fertility, and the surgeon notes the tube is severely damaged and not salvageable.'\",\n  \"medical_accuracy_score\":  \"4\",\n  \"logical_validity\": false,\n  \"logical_false_reason\": \"M\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: ectopic pregnancy visualized at laparoscopy, β-hCG <2000 mIU/mL, small size (1 cm), hemodynamically stable (implied by elective laparoscopy). Main logical issue: The keyed answer (D, salpingectomy) is not the single best answer; option A (methotrexate) is equally defensible per standard guidelines for a small, low-β-hCG ectopic in a stable patient, even after diagnostic laparoscopy, as medical management remains a valid first-line option. The stem lacks critical details (e.g., patient's desire for future fertility, surgeon's assessment of tube viability, or explicit contraindication to methotrexate) to uniquely favor surgery over medicine. Main medical accuracy issue: The rationale overstates the inappropriateness of methotrexate post-laparoscopy; guidelines support either medical or surgical management in this scenario. Minimal fix: Add to the stem: 'The patient expresses a strong desire to preserve fertility, and the surgeon notes the tube is severely damaged and not salvageable.'", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-015", "question": "A 55-year-old woman with treatment-resistant depression has been stable on phenelzine 60 mg daily for 3 years. She presents with acute confusion, fever (39.4°C), hypertonia, and myoclonus after starting amitriptyline 50 mg daily for neuropathic pain 5 days ago. Creatine kinase is 3,500 U/L. After discontinuing amitriptyline and providing supportive care, she develops persistent paranoid delusions and auditory hallucinations. Which of the following antipsychotics carries the LOWEST risk of precipitating serotonin syndrome or hypertensive crisis in this patient?", "options": ["Haloperidol", "Olanzapine", "Quetiapine", "Aripiprazole", "Brexpiprazole"], "answer": "C", "answer_index": 2, "explanation": "Quetiapine has the lowest serotonin reuptake inhibition among antipsychotics, minimizing serotonin syndrome risk when used with MAOIs. Haloperidol has minimal serotonergic effects but high dopamine blockade risks exacerbating parkinsonism after recent serotonin syndrome. Olanzapine has moderate serotonin 5-HT2A antagonism but minimal reuptake inhibition. Aripiprazole and brexpiprazole are partial agonists at 5-HT1A receptors and antagonists at 5-HT2A, with complex serotonergic profiles that could theoretically interact. Quetiapine's metabolite norquetiapine has norepinephrine reuptake inhibition but at therapeutic doses this is minimal. The priority is avoiding serotonergic agents while managing psychosis in a patient on irreversible MAOI.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: patient on irreversible MAOI (phenelzine) with recent serotonin syndrome triggered by serotonergic agent (amitriptyline), now needing antipsychotic for new psychotic symptoms; the question asks for lowest risk of precipitating serotonin syndrome or hypertensive crisis. The item uniquely supports quetiapine as having minimal serotonin reuptake inhibition among the options, aligning with MAOI safety concerns. No logical issues: stem provides sufficient detail (MAOI use, recent serotonin syndrome, need for antipsychotic) to discriminate among options based on serotonergic activity profiles. Medical accuracy: consistent with standard pharmacology; quetiapine is indeed considered lower-risk in this context due to weak serotonergic effects. Minimal fix: none needed; item is clear and accurate.\",\n  \"medical_accuracy_score\":  \"4\",\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: patient on irreversible MAOI (phenelzine) with recent serotonin syndrome triggered by serotonergic agent (amitriptyline), now needing antipsychotic for new psychotic symptoms; the question asks for lowest risk of precipitating serotonin syndrome or hypertensive crisis. The item uniquely supports quetiapine as having minimal serotonin reuptake inhibition among the options, aligning with MAOI safety concerns. No logical issues: stem provides sufficient detail (MAOI use, recent serotonin syndrome, need for antipsychotic) to discriminate among options based on serotonergic activity profiles. Medical accuracy: consistent with standard pharmacology; quetiapine is indeed considered lower-risk in this context due to weak serotonergic effects. Minimal fix: none needed; item is clear and accurate.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-016", "question": "A 23-year-old woman with schizoaffective disorder, bipolar type, maintained on lithium 900 mg daily and paliperidone 6 mg daily, presents with 2 days of worsening confusion, ataxia, and tremors. Serum lithium is 3.2 mEq/L (toxic). She is treated with saline diuresis and recovers. Two weeks later, she is readmitted with recurrence of severe lithium toxicity (level 3.5 mEq/L) despite taking only prescribed lithium. Renal function is normal. Which of the following medication interactions most likely explains the recurrent toxicity?", "options": ["Paliperidone inhibiting renal tubular secretion of lithium", "Undiagnosed nephrogenic diabetes insipidus causing dehydration", "Nonsteroidal anti-inflammatory drug use reducing lithium clearance", "Thiazide diuretic prescribed for pedal edema", "Lithium tablet malabsorption with erratic bioavailability"], "answer": "D", "answer_index": 3, "explanation": "Thiazide diuretics cause sodium depletion, increasing renal lithium reabsorption and dramatically elevating serum levels, even with previously stable dosing. The time course fits with recent thiazide prescription after initial hospitalization. NSAIDs also reduce lithium clearance but typically less dramatically. Paliperidone has no known effect on lithium handling. Nephrogenic DI causes polyuria but not necessarily toxicity unless dehydration occurs. Malabsorption would lower, not increase, levels. Thiazides are often prescribed for lithium-induced edema or hypertension, creating this dangerous interaction that must be avoided in lithium-treated patients.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: Recurrent severe lithium toxicity (3.5 mEq/L) despite normal renal function and prescribed lithium dose, after recovery from initial toxicity. The stem does not mention any new medication, including a thiazide diuretic. The most likely explanation from the options, given the stem's information, is NSAID use (C), as it is a common, well-established cause of reduced lithium clearance. Option D requires an unstated assumption that a thiazide was recently prescribed. Without that information, C is more directly supported by typical clinical scenarios. Main logical issue: The keyed answer (D) is not the single best answer based solely on the stem; the stem is underspecified regarding new medications, but given common interactions, C is more defensible. Main medical accuracy issue: None; all options describe plausible mechanisms, but the key selection is not optimal. Minimal fix: Add to the stem: 'She reports starting ibuprofen for headaches one week prior.' This would make C the unambiguous best answer.\", \"logical_false_reason\": \"K\", \"logical_validity\": false, \"medical_accuracy_score\":  \"4\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: Recurrent severe lithium toxicity (3.5 mEq/L) despite normal renal function and prescribed lithium dose, after recovery from initial toxicity. The stem does not mention any new medication, including a thiazide diuretic. The most likely explanation from the options, given the stem's information, is NSAID use (C), as it is a common, well-established cause of reduced lithium clearance. Option D requires an unstated assumption that a thiazide was recently prescribed. Without that information, C is more directly supported by typical clinical scenarios. Main logical issue: The keyed answer (D) is not the single best answer based solely on the stem; the stem is underspecified regarding new medications, but given common interactions, C is more defensible. Main medical accuracy issue: None; all options describe plausible mechanisms, but the key selection is not optimal. Minimal fix: Add to the stem: 'She reports starting ibuprofen for headaches one week prior.' This would make C the unambiguous best answer.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-017", "question": "A 32-year-old man with borderline intellectual functioning presents with new-onset complex motor tics, coprolalia, and obsessive-compulsive symptoms. He had group A streptococcal pharyngitis 6 weeks prior. Anti-streptolysin O titer is 800 IU/mL. MRI brain shows increased T2 signal in basal ganglia. Which of the following immunomodulatory therapies has demonstrated efficacy in controlled trials for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS)?", "options": ["Intravenous immunoglobulin (IVIG)", "Plasmapheresis", "Oral penicillin prophylaxis", "Intravenous methylprednisolone", "Rituximab"], "answer": "A", "answer_index": 0, "explanation": "While evidence for PANDAS treatments is limited, the randomized controlled trial by Perlmutter et al. (1999) in Lancet demonstrated that IVIG and plasmapheresis were superior to placebo for symptom reduction. IVIG is generally preferred first-line due to lower morbidity than plasmapheresis. Oral penicillin prevents new streptococcal infections but doesn't treat active neuropsychiatric symptoms. IV steroids have anecdotal support but no controlled trial evidence. Rituximab has case reports but no controlled trials. The question specifies proven efficacy in controlled trials, making IVIG (and plasmapheresis) correct, but IVIG is more commonly used as initial immunomodulation.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: M (Multiple answers defensible). Verdict on keyed answer: Not uniquely determinable. Key stem clues: PANDAS diagnosis supported by post-streptococcal neuropsychiatric symptoms, elevated ASO, and basal ganglia MRI changes. Main logical issue: The question asks which immunomodulatory therapy has demonstrated efficacy in controlled trials for PANDAS. Both IVIG (A) and plasmapheresis (B) have demonstrated efficacy in the same landmark controlled trial (Perlmutter et al., 1999), as acknowledged in the provided rationale. This creates two equally evidence-based correct options, violating the single-best-answer principle. Main medical accuracy issue: None; the medical content is accurate. Minimal fix: Revise the stem to specify 'first-line' or 'preferred initial' immunomodulatory therapy to uniquely select IVIG over plasmapheresis.\",\n    \"logical_false_reason\": \"M\",\n    \"logical_validity\": false,\n    \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 5 column 30 (char 967)"}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-018", "question": "A 65-year-old man with recurrent high-grade non-muscle invasive bladder cancer (pT1G3) refractory to BCG and pembrolizumab undergoes radical cystoprostatectomy with ileal conduit. Pathology shows pT2aN0 disease. Six months postoperatively, surveillance CT reveals a 2.5 cm enhancing mass at the left ureteroileal anastomosis. Cystoscopy confirms extrinsic compression. Biopsy shows recurrent urothelial carcinoma. Which of the following management approaches is most appropriate?", "options": ["Systemic chemotherapy with gemcitabine and cisplatin", "Radiation therapy to the anastomotic bed", "Surgical resection with revision of ureteroileal anastomosis", "Intravesical BCG instillation via conduit", "Enfortumab vedotin or sacituzumab govitecan"], "answer": "B", "answer_index": 1, "explanation": "Isolated local recurrence after radical cystectomy with negative margins is rare but potentially curable with radiation therapy. Surgical revision risks extensive adhesions and may not achieve clear margins. Systemic chemotherapy is indicated for metastatic disease but overtreats isolated local recurrence. Intravesical therapy cannot reach the ureteroileal anastomosis. Antibody-drug conjugates like enfortumab are for metastatic disease post-chemo and immunotherapy. Radiation with curative intent (60-66 Gy) offers chance of durable local control without morbidity of reoperation, particularly in medically inoperable patients or those with challenging surgical anatomy.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: isolated local recurrence (2.5 cm mass at anastomosis) after radical cystectomy for pT2aN0 disease, biopsy-proven urothelial carcinoma, extrinsic compression on cystoscopy, no mention of metastases. The most appropriate management for isolated local recurrence after cystectomy is surgical resection if feasible, as it offers the best chance of cure with negative margins. Radiation therapy (keyed answer B) is typically reserved for patients who are not surgical candidates or have positive margins. Option C (surgical resection with revision) is the standard curative approach for resectable isolated recurrence. The item is medically accurate in describing radiation as an option, but it miskeys the best answer. Minimal fix: Change correct answer key to C, or revise stem to specify patient is medically inoperable to justify radiation as best.\", \"logical_false_reason\": \"K\", \"logical_validity\": false, \"medical_accuracy_score\":  \"4\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: isolated local recurrence (2.5 cm mass at anastomosis) after radical cystectomy for pT2aN0 disease, biopsy-proven urothelial carcinoma, extrinsic compression on cystoscopy, no mention of metastases. The most appropriate management for isolated local recurrence after cystectomy is surgical resection if feasible, as it offers the best chance of cure with negative margins. Radiation therapy (keyed answer B) is typically reserved for patients who are not surgical candidates or have positive margins. Option C (surgical resection with revision) is the standard curative approach for resectable isolated recurrence. The item is medically accurate in describing radiation as an option, but it miskeys the best answer. Minimal fix: Change correct answer key to C, or revise stem to specify patient is medically inoperable to justify radiation as best.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-019", "question": "A 62-year-old man with metastatic renal cell carcinoma to L3 vertebra develops rapidly progressive cauda equina syndrome. He undergoes emergent L3 laminectomy with tumor debulking and posterior instrumentation. Postoperatively, he is unable to void and has perianal anesthesia. MRI shows residual tumor compressing the thecal sac. He is started on dexamethasone and referred for radiation oncology consultation. Which of the following radiotherapy parameters is most critical for optimizing neurological recovery while minimizing toxicity?", "options": ["Total dose of 30 Gy in 10 fractions", "Treatment volume limited to involved vertebral body only", "Omitting simultaneous integrated boost to macroscopic disease", "Avoiding concurrent vascular endothelial growth factor (VEGF) inhibitors", "Delaying radiotherapy until 4 weeks postoperatively"], "answer": "A", "answer_index": 0, "explanation": "For metastatic spinal cord compression with residual tumor post-decompression, 30 Gy in 10 fractions is the standard dose providing optimal balance of tumor control and spinal cord tolerance. Larger volumes including entire involved vertebra plus one above/below are needed to cover microscopic disease. Simultaneous boost increases cord toxicity risk. VEGF inhibitors can continue but with dose reduction if concurrent. Delaying radiation beyond 2 weeks increases recurrence risk; ideally start within 7-10 days postoperatively. The total dose-fractionation is most critical as single-fraction (8 Gy) provides less durable control, while higher doses (≥37.5 Gy) increase myelopathy risk without proven benefit.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: rapidly progressive cauda equina syndrome, emergent L3 laminectomy with tumor debulking, residual tumor compressing the thecal sac, started on dexamethasone, referred for radiation oncology consultation. The question asks for the most critical radiotherapy parameter for optimizing neurological recovery while minimizing toxicity. The keyed answer (A: Total dose of 30 Gy in 10 fractions) is a standard dose-fractionation, but the most critical parameter in this postoperative setting with residual compression is timely initiation of radiotherapy to prevent further neurological deterioration and recurrence. Standard guidelines (e.g., ASTRO, ESMO) recommend starting radiotherapy as soon as possible, ideally within 24-48 hours postoperatively or at least within 2 weeks. Delaying until 4 weeks (option E) is clearly harmful. However, among the options, the most critical is avoiding delay, not the specific dose of 30 Gy, which is one of several acceptable regimens. Option E is the worst and most critical to avoid, but the question asks for the most critical parameter to optimize recovery, implying a positive action. The stem does not specify that radiotherapy is delayed, so the critical action is to start promptly, making 'avoiding delay' the key principle. Option A is a reasonable dose but not the most critical parameter compared to timing. The item is miskeyed because the unique best answer is not A; it is E (as the parameter to avoid, but the framing is ambiguous). Main logical issue: Miskeyed. Main medical accuracy issue: Minor; 30 Gy/10 fractions is a standard option, but the emphasis on timing is more critical. Minimal fix: Change the key to E and rephrase the option to 'Initiating radiotherapy within 1-2 weeks postoperatively' to make it a positive critical parameter.\", \"logical_false_reason\": \"K\", \"logical_validity\": false, \"medical_accuracy_score\":  \"4\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: rapidly progressive cauda equina syndrome, emergent L3 laminectomy with tumor debulking, residual tumor compressing the thecal sac, started on dexamethasone, referred for radiation oncology consultation. The question asks for the most critical radiotherapy parameter for optimizing neurological recovery while minimizing toxicity. The keyed answer (A: Total dose of 30 Gy in 10 fractions) is a standard dose-fractionation, but the most critical parameter in this postoperative setting with residual compression is timely initiation of radiotherapy to prevent further neurological deterioration and recurrence. Standard guidelines (e.g., ASTRO, ESMO) recommend starting radiotherapy as soon as possible, ideally within 24-48 hours postoperatively or at least within 2 weeks. Delaying until 4 weeks (option E) is clearly harmful. However, among the options, the most critical is avoiding delay, not the specific dose of 30 Gy, which is one of several acceptable regimens. Option E is the worst and most critical to avoid, but the question asks for the most critical parameter to optimize recovery, implying a positive action. The stem does not specify that radiotherapy is delayed, so the critical action is to start promptly, making 'avoiding delay' the key principle. Option A is a reasonable dose but not the most critical parameter compared to timing. The item is miskeyed because the unique best answer is not A; it is E (as the parameter to avoid, but the framing is ambiguous). Main logical issue: Miskeyed. Main medical accuracy issue: Minor; 30 Gy/10 fractions is a standard option, but the emphasis on timing is more critical. Minimal fix: Change the key to E and rephrase the option to 'Initiating radiotherapy within 1-2 weeks postoperatively' to make it a positive critical parameter.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-020", "question": "A 58-year-old woman with BRCA2 mutation and bilateral breast cancer s/p bilateral mastectomies presents with isolated sternal metastasis. Biopsy confirms estrogen receptor-positive, HER2-negative adenocarcinoma of breast origin. She receives 30 Gy in 10 fractions to the sternum with good pain relief. Six months later, she develops new biopsy-proven breast cancer metastasis to the right humeral head within the previous radiation field. Which of the following factors most significantly increases the risk of radiation-associated second primary malignancy in this patient?", "options": ["Total radiation dose exceeding 30 Gy", "Concurrent hormonal therapy with aromatase inhibitor", "BRCA2 germline mutation", "Age >50 at time of irradiation", "Use of 3D-conformal rather than intensity-modulated radiotherapy"], "answer": "C", "answer_index": 2, "explanation": "BRCA2 mutations confer deficiency in homologous recombination DNA repair, dramatically increasing sensitivity to ionizing radiation and risk of radiation-induced second malignancies. Dose, technique, and age are minor factors compared to genetic predisposition. Concurrent aromatase inhibitors don't significantly increase radiation carcinogenesis. IMRT may increase low-dose bath but not necessarily secondary malignancy risk. The recurrence in-field is likely a recurrence rather than a radiation-induced second primary, but the question asks specifically about radiation-associated malignancy risk. BRCA2 carriers have 3-5 fold increased risk of radiation-induced cancers compared to non-carriers, mandating careful risk-benefit assessment for radiotherapy.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. The question asks which factor most significantly increases the risk of radiation-associated second primary malignancy. The stem provides a patient with a BRCA2 mutation who developed a new metastasis within a prior radiation field. The key discriminating finding is the BRCA2 germline mutation, which is a well-established genetic predisposition that increases sensitivity to ionizing radiation and risk of radiation-induced malignancies. The keyed answer (C) is consistent with this: BRCA2 mutations impair homologous recombination repair, significantly elevating risk compared to other factors like dose, age, or technique. Alternatives are less significant: total dose >30 Gy (A) is not exceptionally high; concurrent hormonal therapy (B) is not a major risk factor; age >50 (D) is a minor factor; and 3D-conformal vs. IMRT (E) involves technique differences with unclear impact on second malignancy risk relative to genetic predisposition. The item is logically valid: a single best answer is defensible based on genetic risk trumping other factors. Medical accuracy is sound, aligning with knowledge that BRCA2 carriers have increased radiation sensitivity. No contradictions or underspecification. Minimal fix: none needed; item is clear and accurate.\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\": \n  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. The question asks which factor most significantly increases the risk of radiation-associated second primary malignancy. The stem provides a patient with a BRCA2 mutation who developed a new metastasis within a prior radiation field. The key discriminating finding is the BRCA2 germline mutation, which is a well-established genetic predisposition that increases sensitivity to ionizing radiation and risk of radiation-induced malignancies. The keyed answer (C) is consistent with this: BRCA2 mutations impair homologous recombination repair, significantly elevating risk compared to other factors like dose, age, or technique. Alternatives are less significant: total dose >30 Gy (A) is not exceptionally high; concurrent hormonal therapy (B) is not a major risk factor; age >50 (D) is a minor factor; and 3D-conformal vs. IMRT (E) involves technique differences with unclear impact on second malignancy risk relative to genetic predisposition. The item is logically valid: a single best answer is defensible based on genetic risk trumping other factors. Medical accuracy is sound, aligning with knowledge that BRCA2 carriers have increased radiation sensitivity. No contradictions or underspecification. Minimal fix: none needed; item is clear and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]